Skip to main content

Table 3 Unadjusted and adjusted Cox regression analysis of factors associated with survival stratified by HBV coinfection status

From: Long-term effect of chronic hepatitis B on mortality in HIV-infected persons in a differential HBV transmission setting

Covariates

Category

CHRa (95% CIs)

p-valueb

AHRc (95% CIs)

p-valueb

HBsAg results (ref. positive)

Positive

1.65 (1.08–2.52)

0.019

0.84 (0.52–1.36)

0.486

Sex (ref. Female)

Male

1.87 (1.53–2.289)

< 0.001

1.39 (1.11–1.76)

0.005

Age (ref. 15–24)

25–34

0.84 (0.49–1.42)

0.512

1.00 (0.54–1.83)

0.991

35–44

1.13 (0.69–1.83)

0.631

1.12 (0.64–1.97)

0.695

45–54

1.22 (0.75–2.00)

0.413

1.13 (0.64–2.00)

0.671

55–64

1.90 (1.14–3.16)

0.014

1.66 (0.91–3.01)

0.096

65+

5.07 (2.93–8.77)

< 0.001

3.41 (1.80–6.49)

< 0.001

Province (ref. Kigali City)

East

0.58 (0.18–1.83)

0.352

0.53 (0.13–2.15)

0.373

North

2.07 (1.57–2.72)

< 0.001

2.03 (1.49–2.78)

< 0.001

South

1.47 (1.06–2.03)

0.019

1.57 (1.10–2.24)

0.013

West

1.64 (1.26–2.14)

< 0.001

1.55 (1.14–2.09)

0.005

Current or former drinker (ref. No)

Yes

3.92 (4.01–6.03)

< 0.001

4.20 (3.32–5.31)

< 0.001

WHO stages (ref. 1&2nd stage)

3&4 stage

1.85 (1.47–2.32)

< 0.001

2.15 (1.68–2.75)

< 0.001

Time since ART initiation (ref. < 7 years)

≥ 7 years

0.66 (0.52–0.84)

0.001

0.53 (0.41–0.70)

< 0.001

Ever smoked (ref. No)

Yes

2.49 (1.62–3.83)

< 0.001

0.92 (0.57–1.49)

0.736

Ever had tuberculosis (ref. No)

Yes

1.92 (1.32–2.79)

0.001

1.33 (0.86–2.06)

0.200

TDF based regimen (ref. No)

Yes

0.95 (0.76–1.20)

0.676

  
  1. aCrude hazard ratio, bChi squared p-value, cadjusted hazard ratio